Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Biogen

These Are The 5 Best Stocks Of The Year; Some You May Not Recognize

Reata Pharmaceuticals stock gained 345% this year through Friday and is a top 2023 stock.

Investors Business Daily

Eli Lilly Stock Has Tumbled 22% Since Its August High. Is It A Buy Or A Sell?

Eli Lilly stock undercut its 50-day line on Jan. 14 after cutting its fourth-quarter and 2024 outlook. Is LLY stock a sell today?

Investors Business Daily

Stock Market Improves; Tesla Stock Falls On Management Change

The stock market posted gains across the board with the Dow and S&P near the day's highs. Mattel stock gets a lift on "Barbie" movie sales.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Morningstar's 8 Favorite Healthcare Stocks

The healthcare sector has trailed far behind the overall stock market so far this year, creating 'opportunities.'

The Street

FDA approves postpartum depression pill

Here’s what we know about the second drug to ever be approved for the post-pregnancy condition

Salon

Five Stocks Morningstar Likes After Earnings Reports

Morningstar assigned all five wide moat (durable competitive advantage) ratings and sees them as undervalued.

The Street

Stock Market Finishes Week Strong; Roku Stock Gains 31% After Company Posts Smaller Loss

The stock market held on to most of Friday's afternoon gains. A solar stock shined while an energy stock got burned.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Biogen Announces $7.3 Billion Acquisition After Outlining Plans To Cut 11% Of Workforce

Biogen says it has agreed to acquire Reata Pharmaceuticals for about $7.3 billion. Reata stock surged as Biogen stock gained ground.

Investors Business Daily

Biogen Stock Tumbles On Plans To Cut 11% Of Workforce; Tops Second-Quarter Estimates

Biogen stock dropped Tuesday after the biotechnology firm said it's eliminating 1,000 jobs as part of a strategy to cut operating expenses.

Investors Business Daily

IBD Stock Of The Day Eli Lilly: How Alzheimer's And Weight Loss Are Driving A New Breakout

Eli Lilly stock is Tuesday's IBD Stock Of The Day. Shares are rising as Lilly's Alzheimer's treatment appears "very competitive" with Biogen's.

Investors Business Daily

FDA Approves Biogen’s Alzheimer’s Drug That Slows Down Cognitive Decline

The FDA fully approved Biogen Inc. but there are other companies with treatments in the pipeline

Zenger

Dow Jones Futures Fall With Jobs Report Due; Meta Leads 7 Resilient Stocks

The jobs report looms with Treasury yields soaring. Meta is among stocks holding up as Threads had record first-day downloads.

Investors Business Daily

FDA approves Leqembi, first drug to slow Alzheimer’s progression

Eisai and Biogen's Leqembi is the first drug to slow Alzheimer's progression to receive full FDA approval.

Axios

FDA grants full approval to new Alzheimer’s drug - Roll Call

The drug Leqembi targets plaque buildup in the brain, and it is approved for people in the early stages of the disease.

Roll Call

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Biogen Skids As Analysts Debate Uptake For Newly Approved Alzheimer's Drug

Biogen stock skidded Friday after the Food and Drug Administration fully approved its Alzheimer's treatment, Leqembi.

Fortune

Fortune 500 companies and CEOs react to end of affirmative action

Fortune 500 companies, including Salesforce and Microsoft, reacted to the Supreme Court's decision to reject affirmative action at U.S. colleges and universities.

StockNews.com

3 Stocks to Own as Alzheimer's Drugs Bring Relief

The number of people with dementia, including those with Alzheimer's disease, are projected to increase from 50+ million now to more than 150 million in 2050, according to Alzheimer's Disease International. Those sheer numbers will mean that investors in certain stocks, producing Alzheimer's drugs to combat the disease, are poised…

Barchart

Stock Index Futures Move Higher as Investors Await Fed Rate Decision, U.S. PPI Data

June S&P 500 futures (ESM23) are up +0.12%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.16% this morning as market participants braced for the Federal Reserve’s interest rate decision while also awaiting crucial U.S. PPI data.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stocks Rally on Expectations the Fed Will Pause Rate Hikes

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed up +0.79%. Stock indexes on Tuesday finished moderately higher, with the...

Barchart

Stocks Climb on the Outlook for the Fed to Pause Rate Hikes

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.42%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.32%. U.S. stocks this morning are moderately higher, with the...

Investors Business Daily

Dow Jones Rallies As Oracle Pops On This; Elon Musk Mocks Short Call Amid Tesla Stock Surge

The Dow Jones rallied. Elon Musk mocked a prominent investor for shorting Tesla stock. Oracle earnings beat after it rose on an analyst call.

The Street

Stocks Higher, Fed Decision, Inflation In Focus, Biogen Surges, Oracle Earnings, Silvio Berlusconi Dies - 5 Things To Know

Stock futures higher ahead of key market tests; Week Ahead: Fed, inflation, retail sales in focus; Biogen surges as FDA panel gives final nod to Alzheimer's treatment; Oracle set for new record high ahead of Q4 earnings and Silvio Berlusconi, billionaire media mogul and former prime minister of Italy, dies…

Investors Business Daily

Dow Jones Futures Rise: Bullish Market Breadth, But Fed Looms; Nvidia Has New Buy Point

A broader market rally is a reason to be bullish long term, but the Fed meeting is one reason to be cautious now. Biogen jumped late Friday. Watch Tesla and Nvidia.

Axios

Experimental Alzheimer's drug endorsed for full approval by FDA advisers

Leqembi could become the first treatment of its kind to receive traditional approval from the FDA.

Investors Business Daily

Biogen Rises After 'Drama-Free' Panel Votes Unanimously In Support Of Alzheimer's Drug

Biogen stock rose Monday after a panel of advisors to the FDA voted unanimously in favor of its newest Alzheimer's treatment.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations